Myeloma Cancer Trials
54767414SMM3001
54767414SMM3001 – A phase III randomized, multicenter study of subcutaneous daratumumab versus active monitoring in subjects with high-risk smoldering multiple myeloma.
-
What type of cancer? What stage?
- Smoldering multiple myeloma.
-
Who is eligible?
- Diagnosed within 5 years.
-
How will I be treated?
- Daratumumab – an antibody-based drug, directed against CD38.
For physicians: more information about this specific trial at clinicaltrials.gov.
-
East Jefferson Cancer Center
4204 Houma Blvd., Suite 510
Metairie, LA 70006
504.988.6300 More information -
East Jefferson Cancer Care
4200 Houma Blvd., 2nd and 3rd floor
Metairie, LA 70006
504.456.5000 More information -
East Jefferson Breast Care
4200 Houma Blvd., 2nd Floor
Metairie, LA 70006
504.503.6289 More information
-
Everything you need to know about ...
Cancer Care
Let’s start with some good news: colorectal cancer diagnoses and mortality rates are on the decline. ...
Continue Reading -
The do’s and don’ts of offering ...
Cancer Care
Each year in the U.S., nearly 2 million people are diagnosed with some type of cancer. If a friend or ...
Continue Reading -
Got your cancer screenings yet? ...
Cancer Care
At your last checkup, your primary care provider recommended you schedule a breast cancer screening this ...
Continue Reading -
Know thyself (and thy risk) by ...
Cancer Care
When you own a house, you take care of it with regular maintenance. When you own a car, you take it to ...
Continue Reading -
Comprehensive cancer care: Going ...
Cancer Care
If you’ve been diagnosed with cancer, you want the care of a team of experts. You’ll find that through ...
Continue Reading